The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New World Screwworm, which poses an emerging threat to U.S. livestock and food security.

(Reuters) -Rocket Pharmaceuticals said on Wednesday that the U.S. Food and Drug Administration has lifted the clinical hold on a mid-stage trial of its gene therapy, less than three months after it was halted due to a patient's death.

The FDA has freed Rocket Pharmaceuticals from a clinical hold, giving the gene therapy developer permission to take flight with its pivotal metabolic disorder trial. | The FDA has freed Rocket Pharmaceuticals from a clinical hold,

A nationwide recall of more than 40,000 units of toothpaste has received the lowest risk level by the Food and Drug Administration. A recall for Sensodyne Pronamel Active Shield Toothpaste for Sensitive Teeth began on August 5 over concerns that "Fresh Mint" tubes were mislabeled "Cool Mint/Whitening." The outer carton was labeled accurately.

The U.S. health regulator has allowed a study of Rocket Pharmaceuticals' gene therapy to resume, less than three months after halting it following a patient's death. The drugmaker's shares soared over 30% in morning trading on Wednesday.

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom.

In light of this, dermatologist Adam Friedman of the George Washington University has shared with Newsweek how you can choose safe and effective protection.

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a